- 1、本文档共33页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
The fate of the three major pharmaceutical enterprises run-off battle (I)
PAGE \* MERGEFORMAT 33
The fate of the three major pharmaceutical enterprises run-off battle (I)
Fu to spread the 21st century medical innovation marketing agency dedicated research group
Outline:
I. Words: decisive three major campaigns to meet the best of times
2, single-product Guoyi why it is so important to
3, OTC products Guoyi single basic conditions for the seven major
4, OTC single-product Guoyi Way
5, expansion accomplishments future: from a single product to multiple products Guoyi Guoyi
6, capital warfare, pharmaceutical companies the ultimate battle
Three run-off campaign to meet the best of times
Fu to spread the 21st century, corporate general manager Lou Xiang-peng
This is a worst-era!
Unprecedented fierce competition in the market, the industry faced a major adjustment, corporate profits to decline in the development of China’s pharmaceutical enterprises into the trough. National Development and Reform Commission released data show that: the pharmaceutical industry in 2006 achieved a total profit of 41.3 billion yuan, an increase of 11.1%, at a historic low. At the same time, the cumulative loss-making enterprises 1368, the industry face a loss of 22.62%, an increase of 27.37%. This is one of the best era!
At the trough of the Chinese pharmaceutical industry, there are some fame, limelight business. Divinity, the pioneer of Renhe, Tongji Tang, Yi Bai, amendment, river, Ling-Feng, Ling Rui, Wanxi, nine Shido, and so businesses, some performance is outstanding, and some other major vendors, and some capital chase, no the rapid rise of China’s pharmaceutical industry is not a successful model!
Fu to spread the 21st century institution believes that the next 3-5 years, China’s pharmaceutical enterprises decisive key to the fate of a few years. The worst is still the best, in fact masters of our own hands.
Looking at the scenery unlimited, being closely watched companies, Fuk Loi found that they actually track the success of the deci
您可能关注的文档
- Status of Traditional Medicine of Ethnic Minorities face construction with Chinese characteristics the national medical system.doc
- State liquor Maotai prices reasonable - 10 to see prices Maotai.doc
- Stellera chameajasme act on human lung cancer cell NCI H446 [H446] the quantitative expression of telomerase.doc
- Stem Cell Research Progress on the treatment of retinal diseases,.doc
- Stem cell therapy of diabetes Recent.doc
- Steel Enterprise Marketing Financial Crisis.doc
- Status of preparation of traditional Chinese medicine treatment of vitiligo_0.doc
- Start miscalculation round loser - Japan's defeat in the Chinese market OS Group Comments.doc
- Steroid hormone GC MS analysis of keto derivatives of Research Progress.doc
- Status of the nature of TCM and the introduction of new trends in systems biology.doc
- 半导体材料性能提升技术突破与应用案例分析报告.docx
- 半导体设备国产化政策支持下的关键技术突破与应用前景报告.docx
- 剧本杀市场2025年区域扩张策略研究报告.docx
- 剧本杀行业2025人才培训体系构建中的市场需求与供给分析.docx
- 剧本杀行业2025年人才培训行业人才培养模式创新与探索.docx
- 剧本杀行业2025年内容创作人才需求报告.docx
- 剧本杀行业2025年区域市场区域剧本市场消费者满意度与市场竞争力研究报告.docx
- 剧本杀市场2025年区域竞争态势下的区域合作策略分析报告.docx
- 剧本杀行业2025人才培训与行业人才培养模式创新.docx
- 剧本杀行业剧本创作人才心理素质培养报告.docx
文档评论(0)